Stay updated on Tepotinib & Gefitinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Tepotinib & Gefitinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tepotinib & Gefitinib in NSCLC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.0 to v3.7.1 on the error page.
    Difference
    0.2%
    Check dated 2026-10-07T00:52:20.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, effectively blocking access to the study record. Most study-related navigation and document links appear to have been removed.
    Difference
    21%
    Check dated 2026-09-23T01:08:50.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The site's revision tag was updated from v3.6.6 to v3.7.0, indicating a new software release; no study content or user-facing features appear to be affected.
    Difference
    0.0%
    Check dated 2026-09-16T00:09:26.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.6.6, replacing the previous v3.6.5. This is a minor, behind-the-scenes update that does not alter the study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-09-01T21:46:22.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    A new line '2016 ( U.S. NIH Grant/Contract )' was added to the study overview alongside other identifiers, representing an additional funding reference for the INSIGHT trial.
    Difference
    0.0%
    Check dated 2026-08-25T22:15:33.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The revision label on the page was updated to v3.6.5, replacing the previous v3.6.4, indicating a new build or update to the underlying page.
    Difference
    0.0%
    Check dated 2026-08-11T21:38:40.000Z thumbnail image

Stay in the know with updates to Tepotinib & Gefitinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tepotinib & Gefitinib in NSCLC Clinical Trial page.